Below is Validea's guru fundamental report for ASSERTIO HOLDINGS INC (ASRT). Of the 22 guru strategies we follow, ASRT rates highest using our Acquirer's Multiple Investor model based on the published ...

Assertio Holdings stock has fallen 8.15% since my updated bullish thesis in March 2023, while the S&P 500 Index has gained 4.95% over the same period. The SPPI deal is expected to give Assertio access ...

The latest price target for Assertio Holdings (NASDAQ:ASRT) was reported by HC Wainwright & Co. on August 12, 2025. The analyst firm set a price target for $3.00 expecting ASRT to fall to within 12 ...

In Q1 FY2023, Assertio achieved significant progress in executing the new strategy brought on board by CEO Dan Peisert. The market expects ASRT's EPS to decline nearly 82% YoY in FY2023, but then ...

Investors interested in Medical - Drugs stocks are likely familiar with Assertio (ASRT) and IPSEN SA ADR (IPSEY). But which of these two stocks offers value investors a better bang for their buck ...

Wall Street Zen cut shares of Assertio (NASDAQ:ASRT – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Other equities research analysts have also recently ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Assertio Therapeutics ( (ASRT)) has ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.